Ronald Sobecks

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series

Sonali M. Smith, Michelle M. Le Beau, Dezheng Huo et al. · Blood · 2003 · 674 citations

Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)

Javier Bolaños‐Meade, Ran Reshef, Raphael Fraser et al. · The Lancet Haematology · 2019 · 274 citations

Versus Tacrolimus, Transplantation, Immunosuppressive Therapy +9

Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning

Navneet S. Majhail, Ruta Brazauskas, J. Douglas Rizzo et al. · Blood · 2010 · 215 citations · Full text

A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation

Brian J. Bolwell, Ronald Sobecks, Brad Pohlman et al. · Bone Marrow Transplantation · 2004 · 203 citations

Mycophenolate Mofetil, Transplantation, Marrow Transplantation +9

A phase I multidose study of dacetuzumab (SGN-40; humanized anti-CD40 monoclonal antibody) in patients with multiple myeloma

M. A. Hussein, James R. Berenson, Rubén Niesvizky et al. · Haematologica · 2010 · 141 citations · Full text

Immunology, Observed Safety Profile, Pharmacotherapy +18